Allergy testing device and method of testing for allergies

• US 9,011,350 B2
• Filed: 06/24/2013
• Issued: 04/21/2015
• Est. Priority Date: 11/30/2011
• Status: Active Grant

• Current Assignee: Concurrent Computer Corporation, Lincoln Diagnostics, Inc.
• Original Assignee: Lincoln Diagnostics, Inc.
• Inventors: Hein, Gary L. Jr., Hein, Douglas S.
• Primary Examiner(s): SZMAL, BRIAN SCOTT
• Application Number:
  US13/925,258
• Publication Number:
  US 20130289440A1
• Time in Patent Office: 666 Days
• Field of Search: 600/556
• US Class Current: 600/556
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/445 Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore

Abstract

An allergy testing system comprises a skin test device having a grip portion for holding the device. One or more legs extend from the grip, and each leg is oriented to interact with a well containing a potential allergen. Each leg has a test head, and each test head has a plurality of elongated spike members. The elongated spike members have a sharp end configured to receive the potential allergen from a well and to puncture a patient'"'"'s skin. In addition, each test head has at least one touch activator. The touch activator is longer than the plurality of elongated spike members, such that during an allergy test, the touch activator comes into contact with the skin prior to the elongated spike members, causing the touch activators to activate nerve tissue that blocks transmission of pain, resulting in a reduction of pain and/or discomfort during testing.

Claims

1. An allergy testing system comprising:

a plurality of wells containing test solutions; and

a skin test device comprising;

an elongated grip portion for holding the device;

a plurality of legs extending from the grip, the plurality of legs spaced and oriented to interact with the plurality of wells containing test solutions;

wherein each of the plurality of legs has a test head, each test head comprising a plurality of elongated spikes each having a sharp end configured to receive test solution from a corresponding well and to puncture skin to deliver the test solution, each test head further comprising at least one touch activator, wherein the touch activator is longer than the plurality of elongated spikes, such that during an allergy test, the touch activator is configured to come into contact with the skin prior to the elongated spikes, to cause the touch activators to activate nerve tissue that suppresses transmission of pain, resulting in a reduction of pain during testing and the plurality of legs being configured such that the test heads maintain the same spacing during testing.

2. The allergy testing system of claim 1, wherein both the touch activator and the plurality of elongated spikes are configured to come into contact with the test solutions and are configured to receive the test solutions by capillary attraction.

3. The allergy testing system of claim 1, wherein the skin test device is formed rigid to maintain the same spacing between each of the plurality of legs during testing.

4. The allergy testing system of claim 1, wherein the skin test device is configured to provide uniform pain management across the skin.

5. The allergy testing system of claim 1, wherein the test heads are configured to provide uniform penetration of the elongated spikes on the skin.

6. The allergy testing system of claim 1, wherein the spacing between the elongated spikes and the touch activator is configured to remain constant.

7. An skin test device comprising:

an elongated grip portion for holding the device;

a plurality of legs extending from the grip, the plurality of legs spaced and oriented to interact with a plurality of wells containing test solutions;

wherein each of the plurality of legs has a test head comprising a plurality of elongated spikes and at least one touch activator; and

wherein the touch activator is longer than the plurality of elongated spikes, such that during an allergy test, the touch activator is configured to come into contact with the skin prior to the elongated spikes, to cause the touch activators to activate nerve tissue that suppresses transmission of pain, resulting in a reduction of pain during testing and the plurality of legs being configured such that the test heads maintain the same spacing during testing.

8. The skin test device of claim 7 wherein the skin test device is formed rigid.

9. The skin test device of claim 7, wherein both the touch activator and the plurality of elongated spikes are configured to come into contact with the test solutions and are configured to receive the test solutions by capillary attraction.

10. The skin test device of claim 8, wherein plurality of legs are formed rigid to maintain the same spacing.

11. The skin test device of claim 7, wherein the test heads provide uniform pain management across the skin.

12. The skin test device of claim 7, wherein the test heads are configured to provide uniform penetration for the elongated spikes on the skin.

13. The skin test device of claim 7, wherein the spacing between the elongated spikes and the touch activator is configured to remain constant.

14. A skin test device comprising:

a grip portion for holding the skin test device;

at least one leg extending from the grip portion, each leg oriented to interact with a well containing a test solution; and

wherein the at least one leg has a test head comprising a plurality of elongated spikes and at least one touch activator, the plurality of elongated spikes each have a sharp end configured to receive the test solution from a well and to puncture skin for delivering the test solution, the touch activator and the elongated spikes are configured to maintain the same spacing during testing, and the touch activator is longer than the plurality of elongated spikes, such that during an allergy test, the touch activator is configured to come into contact with the skin prior to the elongated spikes, to cause the touch activator to activate nerve tissue that suppresses pain, resulting in a reduction of pain during testing.

15. The skin test device of claim 14 further comprising a rigid body.

16. The skin test device of claim 14, wherein both the touch activator and the plurality of elongated spikes are configured to come into contact with the test solutions and are configured to receive the test solutions by capillary attraction.

17. The skin test device of claim 14, wherein the spacing between the elongated spikes and the touch activator is configured to remain constant.

18. The skin test device of claim 14, wherein the test head is configured to provide uniform penetration of the elongated spikes on the skin.